Dovonex

Product manufactured by Leo Pharma Inc.

Application Nr Approved Date Route Status External Links
NDA020554 1996-07-22 Topical RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Dovonex® (calcipotriene) Cream, 0.005%, Is Indicated For The Treatment Of Plaque Psoriasis. The Safety And Effectiveness Of Topical Calcipotriene In Dermatoses Other Than Psoriasis Have Not Been Established.

All Formulated Excipients (9 Total)

Name Structure Kind Function Status
1. Ceteth-20 CETETH-20 Unresolved
2. Diazolidinyl Urea DIAZOLIDINYL UREA Molecular
3. Dichlorobenzyl Alcohol DICHLOROBENZYL ALCOHOL Molecular
4. Sodium Phosphate, Dibasic SODIUM PHOSPHATE, DIBASIC Molecular
5. Edetate Disodium EDETATE DISODIUM Molecular
6. .alpha.-Tocopherol, Dl- .ALPHA.-TOCOPHEROL, DL- Molecular
7. Glycerin GLYCERIN Molecular MISC-Miscellaneous FS-Substances permitted as optional ingredient in a standardized food.
8. Mineral Oil MINERAL OIL Unresolved
9. Petrolatum PETROLATUM Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Calcipotriene CALCIPOTRIENE ZINC3921872

Comments